SG Americas Securities, LLC

Broker-Dealer

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1313360 NEW YORK, NY

Position in AMLX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$993,565

+$741,746 QoQ

Shares Held

55,321

+165.4% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#97

of 207 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $334,347,383 across 35 Drug Manufacturers - Specialty & Generic names. AMLX ranks #16 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,264,647	$90,877,533
2	UTHR	UNITED THERAPEUTICS Corp	89,893	$48,706,724
3	TEVA	Teva Pharmaceutical Industries Ltd	1,282,256	$43,442,833
4	KNSA	Kiniksa Pharmaceuticals International, plc	504,001	$32,230,863
5	BHC	Bausch Health Companies Inc.	5,535,771	$27,291,351
6	VTRS	Viatris Inc	1,533,471	$24,351,519
7	NBIX	Neurocrine Biosciences Inc	141,613	$23,867,455
8	INDV	Indivior Pharmaceuticals, Inc.	324,134	$13,299,218

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$993,565	55,321	+165.4%	Shares	Sole	2026-08-07
2025-12-31	$251,819	20,846	+76.4%	Shares	Sole	2026-01-09
2025-09-30	$160,620	11,819	-53.1%	Shares	Sole	2025-10-23
2025-03-31	$89,243	25,210	+58.0%	Shares	Sole	2025-04-15
2024-12-31	$60,321	15,958	-72.2%	Shares	Sole	2025-01-17
2024-09-30	$185,930	57,386	+2.8%	Shares	Sole	2024-10-03
2024-06-30	$106,088	55,836	+113.6%	Shares	Sole	2024-07-12
2024-03-31	$74,234	26,139	-60.4%	Shares	Sole	2024-05-06
2023-12-31	$972,094	66,039	+210.7%	Shares	Sole	2024-01-12
2023-09-30	$389,179	21,255	+155.5%	Shares	Sole	2023-10-13
2023-06-30	$179,440	8,319	-9.5%	Shares	Sole	2023-07-10
2023-03-31	$269,575	9,188	-12.4%	Shares	Sole	2023-04-28
2022-12-31	$387,568	10,489	—	Shares	Sole	2023-02-02
No filing history on record for this holder in this stock.